newsfilter
← Latest News
PR Newswire·

BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare...